Evidence map›Paper›PMID 34884495›Full record

ReviewInternational journal of molecular sciences2021

The ECM: To Scaffold, or Not to Scaffold, That Is the Question.

Jonard Corpuz Valdoz, Benjamin C Johnson, Dallin J Jacobs, Nicholas A Franks, Ethan L Dodson, Cecilia Sanders, Collin G Cribbs, Pam M Van Ry

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed.

  1. Bioprinting of miRNA-Induced Spheroids for Vascularized, Heterocellular Bone Regeneration.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Novel emerging cell and organoid systems for the study of drug metabolism and toxicity in humans.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jonard Corpuz ValdozDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.ORCID 0000-0002-7106-1009
Benjamin C JohnsonDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Dallin J JacobsDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Nicholas A FranksDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Ethan L DodsonDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Cecilia SandersDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Collin G CribbsDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Pam M Van RyDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.ORCID 0000-0003-0195-7229

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extracellular matrix (ECM) has pleiotropic effects, ranging from cell adhesion to cell survival. In tissue engineering, the use of ECM and ECM-like scaffolds has separated the field into two distinct areas-scaffold-based and scaffold-free. Scaffold-free techniques are used in creating reproducible cell aggregates which have massive potential for high-throughput, reproducible drug screening and disease modeling. Though, the lack of ECM prevents certain cells from surviving and proliferating. Thus, tissue engineers use scaffolds to mimic the native ECM and produce organotypic models which show more reliability in disease modeling. However, scaffold-based techniques come at a trade-off of reproducibility and throughput. To bridge the tissue engineering dichotomy, we posit that finding novel ways to incorporate the ECM in scaffold-free cultures can synergize these two disparate techniques.

Indexed as

BiomimeticsCell AdhesionAnimalsCell DifferentiationCell SurvivalExtracellular MatrixHumansTissue EngineeringTissue ScaffoldsECMhydrogelorganoidsscaffold-basedscaffold-freespheroidstissue engineering

Identifiers

PMID34884495
PMCPMC8657545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.